Eleven Biotherapeutics, Inc. of CAMBRIDGE, MA, a company, filed a Form D amendment with the SEC on 2010-10-13. The offering totals $35.0M, of which $8.8M was reported sold. Industry: Biotechnology.
Showing 25 of 32 people.
| Name | Role | Location |
|---|---|---|
| Noubar B Afeyan | Director | Cambridge, MA |
| David M Berry | Director | Cambridge, MA |
| Mark Levin | Director | New York, NY |
| Cary B Pfeffer | Director | Cambridge, MA |
| Kim C Drapkin | Executive Officer | Boston, MA |
| Mark Levin | Executive Officer | New York, NY |
| Cary B Pfeffer | Executive Officer | Cambridge, MA |
| Gregory D Perry | Executive Officer | Arlington, MA |
| Cary G Pfeffer | Director | Baltimore, MD |
| Daniel S Lynch | Director | Cambridge, MA |
| Barry J Gertz | Director | Cambridge, MA |
| Richard F Fitzgerald | Executive Officer | Cambridge, MA |
| Leslie G Dan | Director | Cambridge, MA |
| Jane V Henderson | Director | Cambridge, MA |
| Paul G Chaney | Director | Cambridge, MA |
| Stephen A Hurly | Director | Cambridge, MA |
| Stephen A Hurly | Executive Officer | Cambridge, MA |
| Abbie C Celniker | Director | Cambridge, MA |
| Jay S Duker | Director | Cambridge, MA |
| Stephen V Hurly | Director | Cambridge, MA |
| Stephen V Hurly | Executive Officer | Cambridge, MA |
| John C McCabe | Executive Officer | Cambridge, MA |
| Abbie C Celniker, Ph.D. | Director | Cambridge, MA |
| Abbie C Celniker, Ph.D. | Executive Officer | Cambridge, MA |
| Leslie V Dan | Director | Cambridge, MA |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2018-04-05 | D | $996K | $996K |
| 2016-09-28 | D | $13.5M | $13.5M |
| 2014-12-05 | D | $20.0M | $20.0M |
| 2010-02-24 | D | $35.0M | $4.5M |